Allergan moves away from $200m plant expansion in Texas 05-Nov-2018 By Ben Hargreaves The decision, influenced by the expected loss of exclusivity for Restasis, will allow the company to ‘improve efficiencies’ across its manufacturing network, a spokesperson explained.